Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/19/2007
Trade Name:
Hepsera
Generic or Proper Name (*):
adefovir dipivoxil
Indications Studied:
Chronic hepatitis B virus infection
Therapeutic Category:
Antiviral
Ages Studied:
2-18 years
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Single-Blind/Placebo/Parallel Group
No Patients:
173
No Centers:
26
No Countries:
6
BPCA(B), PREA(P):
B, P
Asian:
41
Black:
14
Other:
6
White:
111
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
1
-
-